Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 12:21 AM
NCT ID:
NCT02421458
Eligibility Criteria:
Inclusion Criteria:
• Newly diagnosed patients with primary non-metastatic carcinoma located in the oral cavity, oropharynx, larynx (except T1 glottic), hypopharynx, nasopharynx, paranasal sinuses and salivary gland and carcinoma of unknown primary in the head and neck region who are not suitable for radical treatment with surgery or (chemo) and, therefore, planned for treatment with radiotherapy in palliative setting.
OR
* Newly diagnosed patients with primary head and neck carcinoma with limited metastatic disease in a good general condition and few comorbidities (ACE-25 \<3) with life expectancy of at least 6 months are also eligible.
* No chemotherapy or surgery is allowed before inclusion.
* Age ≥ 18 years
* WHO performance status 0-2
* Signed written informed consent
Exclusion Criteria:
* Patients with previously radiation treatment in the head and neck region, for any reason.
\* Chemotherapy or surgery for head and neck tumor before inclusion and no other concomitant anti-cancer therapy is allowed during study treatment.
* Patients with head and neck malignancies arising from skin, nose, thyroid gland or esophagus.
* Patients with advanced stage sarcoma or lymphoma of the head and neck region.
* Expected life expectancy of less than 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02421458
Study Brief:
Protocol Section:
NCT02421458